Neola Medical AB

NEOLA · Nasdaq Stockholm · Healthcare

0.49SEK −0.8%last day

Price as of 2 October 2026

The price over the past year, with dividends: −77.1%

Performance

1 month

−3.9%

1 year

−77.1%

3 years, per year

−27.0%

5 years, per year

−29.2%

Largest fall, 3 years

−85.4%

Below the peak now

−92.2%

Volatility, 1 year

121.3%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

0.4

Dividend yield

0.0%

Return on equity

−13.0%

Net margin

–

Market value

4 m USD

Quality, value and trend

Where Neola Medical stands against every Nordic stock today. 100 is best.

Quality79

Profitability and a sound balance sheet over time. Better than 79% of Nordic stocks.

Value27

The price measured against earnings, assets and cash flow. Better than 27% of Nordic stocks.

Trend3

The price development over the past year. Better than 3% of Nordic stocks.

Combined23

Quality, value and trend together. Better than 23% of Nordic stocks.

About Neola Medical

Neola Medical AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 9 employees.

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis